Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Pembrolizumab | Pembrolizumab Inhibitor. Uses: Scientific use. Product Category: T9908. CAS No. 1374853-91-4. |  |
| Pembrolizumab | Pembrolizumab (MK-3475) is a humanized IgG4 antibody inhibiting the programmed cell death 1 ( PD-1 ) receptor, used in cancer immunotherapy. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MK-3475; Lambrolizumab. CAS No. 1374853-91-4. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P9902. |  |
| Pembrolizumab (anti-PD-1) | Pembrolizumab (anti-PD-1) is a humanized IgG4 antibody and PD-1 inhibitor. Pembrolizumab produces PD-1 blockade, preventing PD-L1 and PD-L2 from connecting to PD-1. This avoids the uncontrolled regulation of T cells on cells that normally express PD-1[1][2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MK-3475 (anti-PD-1); Lambrolizumab (anti-PD-1). Pack Sizes: 1 mg; 5 mg. Product ID: HY-P9902A. | |
| ARRY-382 | ARRY-382 is a potent and selective inhibitor of the CSF1R with IC50 of 9 nM. ARRY-382 can be combined with Pembrolizumab for the treatment of advanced solid tumors. Synonyms: c-Fms-IN-12; ARRY382; ARRY 382. CAS No. 1313407-95-2. Molecular formula: C32H36N8O2. Mole weight: 564.68. |  |
| Favezelimab | Favezelimab (MK-4280) is a humanized anti-LAG-3 monoclonal antibody that blocks the interaction between LAG-3 and its ligand MHC class II. Favezelimab has the potential for colorectal cancer (CRC) research combined with the PD-L1 inhibitor Pembrolizumab (HY-P9902) [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: MK-4280. CAS No. 2231068-83-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99613. | |
| MK-1084 | MK-1084 is a selective KRAS G12C inhibitor that is currently in Phase I clinical trial (NCT05067283). MK-1084 exhibits anticancer activity and can be used either alone or in combination with pembrolizumab (HY-P9902) for cancer research [1]. Uses: Scientific research. Group: Signaling pathways. CAS No. 2641216-67-1. Pack Sizes: 1 mg; 5 mg. Product ID: HY-162431. | |
Our database is helping our users find suppliers everyday.
